Top Players Covered in the Insulin Pump Market Research Report are Medtronic (Ireland), Insulet Corporation (USA), YPSOMED (Switzerland), F.Hoffmann-La Roche Ltd. (Switzerland), Tandem Diabetes Care, Inc. (USA) and other key market players

Pune, India, May 12, 2021 (GLOBE NEWSWIRE) -- The global insulin pump market size is projected to reach USD 11.86 billion by 2028, exhibiting a CAGR of 16.0% during the forecast period. According to a report published by Fortune Business Insights, titled “Insulin Pump Market, 2021-2028”, the market’s value was USD 3.62 billion in 2020.

Development of AI-powered Diabetes Management Devices to Invigorate Market Growth

Leading medical device companies are investing heavily in innovation to design and development diabetes management solutions powered by advanced technologies such as artificial intelligence (AI). For example, in June 2020, the artificial pancreas algorithm developed by DreaMed Diabetes was incorporated into Medtronic’s MiniMed 780G hybrid closed-loop insulin delivery system. DreaMed had also successfully secured approval from the US Food and Drug Administration (FDA) in September 2019 for its AI-driven insulin dosage support solution, DreaMed Advisor Pro, for people with Type 1 diabetes. Medtronic has also been expanding its AI-based insulin pump portfolio. For example, in December 2019, Medtronic acquired California-based Klue, an AI specialist whose technology Medtronic has been integrating with its Personalized Closed Loop system. Thus, the advent of AI in insulin delivery solutions has broadened the growth avenues of this market.

Industry Development

• September 2020: Medtronic received the green light for its MiniMed 770G insulin pump system from the USFDA. Building on the 670G system, the 770G features smartphone connectivity and is also embedded with indications for ages 2 and above.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/insulin-pump-market-102735

Onset of Diabetes in Recovering COVID-19 Patients May Favor Market Growth

While evidence suggesting an increased severity of COVID-19 in diabetics is well-documented, new research has found that recovering coronavirus patients are at an elevated risk of developing diabetes due to weakened organ functioning. In May 2021, a research team from Missouri’s Veterans Affairs St. Louis Health Care System revealed that COVID-19 non-diabetic survivors have a 39% increased likelihood of developing diabetes within six months following the infection. Similar findings were published by a group of researchers from the Office of National Statistics, UK, University of Leicester, UK, University College London, and Royal London Hospital. According to this study, coronavirus patients have a 50% increased likelihood to develop diabetes within 20 weeks of discharge. The complex linkage between diabetes and COVID-19 is thus expected to heighten the demand for efficient diabetes management devices, with insulin pumps leading the charge.

However, despite these favorable circumstances, the insulin pump market growth is likely to be stymied amid the COVID-19 pandemic as hospitals, clinics, and health professionals are devoting all their energies to treat coronavirus patients. In consequence, non-essential procedures have been postponed, affecting this market in the process. In 2020, the market registered a lower growth of 11.7% and it is expected to reach USD 4.13 billion in 2021.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/insulin-pump-market-102735

Highlights of the Report

The report shares a panoramic overview of the overall industry outlook, as well as comprehensive research into the key market drivers and trends. Further, the report also contains a detailed evaluation of the market hindrances, along with a precise computation of relevant market figures. In addition, the report also supplies valuable insights into the regional dynamics and competitive milieu of the market.

Regional Insights

Strong Prevalence of Top Medical Device Companies to Support North America Market Growth

North America is expected to dominate the insulin pump market share during the forecast period as the region is home to some of the biggest medical device manufacturers, such as Insulet and Tandem. Even European companies such as Medtronic have established a strong base in the US and Canada, further bolstering the regional market growth. In 2020, the North America market size stood at USD 2.12 billion.

The market in Europe is slated to be driven by the increasing prevalence of diabetes. For example, the World Health Organization (WHO) estimates that roughly 60 million people across Europe are affected by diabetes. In Asia Pacific, the adoption of insulin pumps will be propelled by the rising incidence of diabetes and an increasing number of older persons, especially in Japan, who are prone to developing chronic metabolic illnesses.

Quick Buy Insulin Pump Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102735

Supportive Regulatory Environment to Stoke Innovation

Key insulin pump and other insulin delivery system manufacturers are focused on building a portfolio of innovative offerings, with robust support from regulatory bodies such as the USFDA. Taking cognizance of the rapidly growing prevalence of diabetes in the US and elsewhere, these bodies are giving speedy approvals to new diabetes management devices and solutions, thus augmenting the potential of this market.

List of Key Players Covered in the Insulin Pump Market Report

• Medtronic (Ireland)

• Insulet Corporation (USA)

• YPSOMED (Switzerland)

• F. Hoffmann-La Roche, Ltd. (Switzerland)

• Tandem Diabetes Care, Inc. (USA)

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/insulin-pump-market-102735

Detailed Table of Content:

• Introduction

  • Research Scope

  • Market Segmentation

  • Research Methodology

  • Definitions and Assumptions

• Executive Summary

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

• Key Insights

  • Ageing Population, Prevalence and Cost Burden of Diabetes, Key Countries, 2019

  • Evolution of Insulin Pumps

  • Total Addressable Market and Insulin Pump Penetration

  • Reimbursement Scenario, in Key Countries

  • Impact of Covid-19 on the Market

  • Comparison Based on Selective Parameters – Major Insulin Pump Manufacturers

  • Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)

• Global Insulin Pump Market Analysis, Insights and Forecast, 2017-2028

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Product Type

    • Pumps

      • Tethered Pumps

      • Patch Pumps

      • Others

    • Consumables

  • Market Analysis, Insights and Forecast – By Disease Indication

    • Type 1 Diabetes

    • Type 2 Diabetes

  • Market Analysis, Insights and Forecast – By Distribution Channel

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Stores

  • Market Analysis, Insights and Forecast – By Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

• North America Insulin Pump Market Analysis, Insights and Forecast, 2017-2028

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Product Type

    • Pumps

      • Tethered Pumps

      • Patch Pumps

      • Others

    • Consumables

  • Market Analysis, Insights and Forecast – By Disease Indication

    • Type 1 Diabetes

    • Type 2 Diabetes

  • Market Analysis, Insights and Forecast – By Distribution Channel

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Stores

  • Market Analysis, Insights and Forecast – By Country

    • U.S.

    • Canada

• Europe Insulin Pump Market Analysis, Insights and Forecast, 2017-2028

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Product Type

    • Pumps

      • Tethered Pumps

      • Patch Pumps

      • Others

    • Consumables

  • Market Analysis, Insights and Forecast – By Disease Indication

    • Type 1 Diabetes

    • Type 2 Diabetes

  • Market Analysis, Insights and Forecast – By Distribution Channel

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Stores

  • Market Analysis, Insights and Forecast – By Countries/ Sub-region

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

    • Scandinavia

    • Rest of Europe

TOC Continued…!!!!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/insulin-pump-market-102735

Have a Look at Related Reports:

Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025

Hemostats Market Size, Share and Global Trend By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery & Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers) and Geography Forecast till 2025

MRI Equipment Market Size, Share & Industry Analysis, By Strength (Less than 1.5 T, 1.5 T, and More than 1.5 T), By Application (Musculoskeletal, Neurology, Cardiology, Body Imaging, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and Regional Forecast, 2019-2027

Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press: https://www.fortunebusinessinsights.com/press-release/india-insulin-pumps-market-9434